The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma

Clinical trial NCT05741359 · RECRUITING

Trial details

NCT number: NCT05741359
Sponsor: Bioray Laboratories
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-hodgkin Lymphoma,B Cell

Start date: 2023-04-25
Primary completion: 2026-11-20
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.